TVTX vs. ATRA

Last updated Jun 24, 2026

TVTX (Travere Therapeutics, Inc.) and ATRA (Atara Biotherapeutics, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 10 years, TVTX returned 12.13%/yr vs -32.12%/yr for ATRA. At a 0.37 correlation, their price movements are largely independent.

Performance

TVTX vs. ATRA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Travere Therapeutics, Inc. (TVTX) and Atara Biotherapeutics, Inc. (ATRA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, TVTX achieves a 46.43% return, which is significantly higher than ATRA's -38.31% return. Over the past 10 years, TVTX has outperformed ATRA with an annualized return of 12.13%, while ATRA has yielded a comparatively lower -32.12% annualized return.

TVTX

• 1D: 1.52%
• 1M: 25.93%
• YTD: 46.43%
• 6M: 58.23%
• 1Y: 286.13%
• 3Y*: 51.34%
• 5Y*: 29.40%
• 10Y*: 12.13%

ATRA

• 1D: 5.18%
• 1M: 13.88%
• YTD: -38.31%
• 6M: -36.23%
• 1Y: 41.62%
• 3Y*: -36.70%
• 5Y*: -51.47%
• 10Y*: -32.12%

*Multi-year figures are annualized to reflect compound growth (CAGR)

TVTX vs. ATRA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
TVTX Travere Therapeutics, Inc.	46.43%	119.35%	93.77%	-57.25%	-32.25%	13.89%	91.94%	-37.25%	7.40%	11.30%
ATRA Atara Biotherapeutics, Inc.	-38.31%	35.91%	3.82%	-84.37%	-79.19%	-19.71%	19.19%	-52.59%	91.93%	27.46%

Correlation

The correlation between TVTX and ATRA is 0.24, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.24
Correlation (3Y) Calculated over the trailing 3-year period	0.26
Correlation (5Y) Calculated over the trailing 5-year period	0.34
Correlation (10Y) Calculated over the trailing 10-year period	0.36
Correlation (All Time) Calculated using the full available price history since Oct 16, 2014	0.37

The correlation between TVTX and ATRA shifts across timeframes, from 0.24 (1 year) to 0.37 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap TVTX : $5.14B ATRA : $157.14M
EPS TVTX : -$0.49 ATRA : -$0.72
PS Ratio TVTX : 9.75 ATRA : 6.50
Total Revenue (TTM) TVTX : $536.20M ATRA : $22.62M
Gross Profit (TTM) TVTX : $385.20M ATRA : $21.73M
EBITDA (TTM) TVTX : $11.15M ATRA : -$6.92M

Return for Risk

TVTX vs. ATRA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TVTX

TVTX Risk / Return Rank: 97
TVTX Sharpe Ratio Rank: 98
TVTX Sortino Ratio Rank: 97
TVTX Omega Ratio Rank: 96
TVTX Calmar Ratio Rank: 97
TVTX Martin Ratio Rank: 96

ATRA

ATRA Risk / Return Rank: 61
ATRA Sharpe Ratio Rank: 53
ATRA Sortino Ratio Rank: 69
ATRA Omega Ratio Rank: 75
ATRA Calmar Ratio Rank: 55
ATRA Martin Ratio Rank: 54

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TVTX vs. ATRA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Travere Therapeutics, Inc. (TVTX) and Atara Biotherapeutics, Inc. (ATRA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	TVTX	ATRA	Difference
Sharpe ratio: Return per unit of total volatility	4.02	0.29	+3.73
Sortino ratio: Return per unit of downside risk	4.57	1.59	+2.98
Omega ratio: Gain probability vs. loss probability	1.58	1.25	+0.33
Calmar ratio: Return relative to maximum drawdown	8.61	0.54	+8.06
Martin ratio: Return relative to average drawdown	19.91	0.94	+18.97

TVTX vs. ATRA - Sharpe Ratio Comparison

The current TVTX Sharpe Ratio is 4.02, which is higher than the ATRA Sharpe Ratio of 0.29. The chart below compares the historical Sharpe Ratios of TVTX and ATRA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

TVTX vs. ATRA - Drawdown Comparison

The maximum TVTX drawdown since its inception was -85.43%, smaller than the maximum ATRA drawdown of -99.74%. Use the drawdown chart below to compare losses from any high point for TVTX and ATRA.

Drawdown Indicators

	TVTX	ATRA	Difference
Max Drawdown Largest peak-to-trough decline	-85.43%	-99.74%	+14.31%
Max Drawdown (1Y) Largest decline over 1 year	-33.49%	-76.89%	+43.40%
Max Drawdown (3Y) Largest decline over 3 years	-69.51%	-92.76%	+23.25%
Max Drawdown (5Y) Largest decline over 5 years	-83.12%	-99.16%	+16.04%
Max Drawdown (10Y) Largest decline over 10 years	-83.64%	-99.68%	+16.04%
Current Drawdown Current decline from peak	0.00%	-99.30%	+99.30%
Average Drawdown Average peak-to-trough decline	-41.00%	-74.08%	+33.08%
Ulcer Index Depth and duration of drawdowns from previous peaks	14.45%	44.55%	-30.10%

Volatility

TVTX vs. ATRA - Volatility Comparison

The current volatility for Travere Therapeutics, Inc. (TVTX) is 15.22%, while Atara Biotherapeutics, Inc. (ATRA) has a volatility of 21.04%. This indicates that TVTX experiences smaller price fluctuations and is considered to be less risky than ATRA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	TVTX	ATRA	Difference
Volatility (1M) Calculated over the trailing 1-month period	15.22%	21.04%	-5.82%
Volatility (6M) Calculated over the trailing 6-month period	52.26%	131.85%	-79.59%
Volatility (1Y) Calculated over the trailing 1-year period	71.62%	143.83%	-72.21%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	66.49%	122.06%	-55.57%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	58.38%	100.25%	-41.87%

Dividends

TVTX vs. ATRA - Dividend Comparison

Neither TVTX nor ATRA has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both TVTX and ATRA in my portfolio?

TVTX and ATRA have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, TVTX or ATRA?

ATRA has higher volatility (21.04%) compared to TVTX (15.22%). In terms of maximum drawdown, TVTX dropped -85.43% vs ATRA's -99.74%.

Which has better risk-adjusted returns?

TVTX currently has the higher Sharpe Ratio (4.02 vs 0.29), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.